Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2012 Feb 2;109(8):3161–3166. doi: 10.1073/pnas.1121434109

Membrane-localized β-subunits alter the PIP2 regulation of high-voltage activated Ca2+ channels

Byung-Chang Suh a,b,1, Dong-Il Kim a, Björn H Falkenburger b, Bertil Hille b,1
PMCID: PMC3287006  PMID: 22308488

Abstract

The β-subunits of voltage-gated Ca2+ (CaV) channels regulate the functional expression and several biophysical properties of high-voltage–activated CaV channels. We find that CaV β-subunits also determine channel regulation by the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2). When CaV1.3, -2.1, or -2.2 channels are cotransfected with the β3-subunit, a cytosolic protein, they can be inhibited by activating a voltage-sensitive lipid phosphatase to deplete PIP2. When these channels are coexpressed with a β2a-subunit, a palmitoylated peripheral membrane protein, the inhibition is much smaller. PIP2 sensitivity could be increased by disabling the two palmitoylation sites in the β2a-subunit. To further test effects of membrane targeting of CaV β-subunits on PIP2 regulation, the N terminus of Lyn was ligated onto the cytosolic β3-subunit to confer lipidation. This chimera, like the CaV β2a-subunit, displayed plasma membrane localization, slowed the inactivation of CaV2.2 channels, and increased the current density. In addition, the Lyn-β3 subunit significantly decreased CaV channel inhibition by PIP2 depletion. Evidently lipidation and membrane anchoring of CaV β-subunits compete with the PIP2 regulation of high-voltage–activated CaV channels. Compared with expression with CaV β3-subunits alone, inhibition of CaV2.2 channels by PIP2 depletion could be significantly attenuated when β2a was coexpressed with β3. Our data suggest that the CaV currents in neurons would be regulated by membrane PIP2 to a degree that depends on their endogenous β-subunit combinations.

Keywords: M1 muscarinic receptor, voltage-sensing phosphatase


Voltage-gated Ca2+ (CaV) channels define excitable cells. These channels contribute to electrical excitability and Ca2+-dependent processes, such as neurotransmitter release, motility, and gene expression (1). An intriguing aspect of CaV channels is their slow, voltage-independent modulation by Gq protein-coupled receptors (GqPCRs) (25). The several proposed mechanisms for this slow modulation of CaV channels include depletion of phosphatidylinositol 4,5-bisphosphate (PIP2) via activation of phospholipase C (310), phosphorylation by protein kinases (11, 12), generation of arachidonic acid by phospholipase A2 (13, 14), and other unspecified pathways involving Gαq or Gβγ-subunits (15, 16). In the nervous system, the dissection of GqPCR modulation of Ca2+ channels is made difficult by the generation of several second messengers and by the existence of multiple subtypes of CaV channels.

CaV channels are a complex of three protein subunits. The α1-subunit forms the voltage-sensitive, Ca2+-selective pore and is the target of selective antagonists. The other auxiliary subunits shape the physiological properties of the α1-subunit. Here we emphasize β-subunits. These subunits associate tightly with the cytoplasmic domain of the α1-subunit, imparting increased peak currents, altered rates of activation and inactivation, and increased density of functional channels (1719). The β-subunits have four known genes (β1–β4) and several splice variants. Single neurons express multiple types in a tissue-specific manner (20, 21). Accordingly, different combinations of α1- and β-isoforms result in heterogeneous CaV channels susceptible to differential regulation.

Some CaV β-subunits are subject to posttranslational modification. The β2a-subunit is doubly palmitoylated (22), which targets it to the plasma membrane even in the absence of a coexpressed α1-subunit (23, 24). Palmitoylation confers on nonmembrane proteins membrane-targeting to specific areas, such as to caveolae for endothelial nitric oxide synthase (25) or the plasma membrane for src-related tyrosine kinases (26). In heterologous expression systems, the β2a-subunit slows CaV current inactivation significantly more than any other β-subunit isoform (27, 28). Studies with chimeric β-subunits demonstrated that cysteine residues in positions 3 and 4 of the N terminus are the sites for palmitoylation and are determinants of CaV channel inactivation (24, 27).

Membrane lipids are implicated in voltage-independent regulation of CaV channels (see reviews in refs. 4, 9, and 29). Wu et al. (7) and Gamper et al. (8) reported that membrane PIP2 dramatically regulates CaV2.1 P/Q-type and CaV2.2 N-type channel activity. The authors found spontaneous rundown of current was opposed or reversed by the application of PIP2 or Mg-ATP and accelerated by PIP2 antibody applied to the cytoplasmic side of excised membrane patches. The authors proposed that depletion of PIP2 on the plasma membrane is the cause of the Gq receptor-mediated slow inhibition of CaV currents in neurons. In contrast, Rittenhouse and colleagues (13, 14) reported that arachidonic acid mediates the muscarinic inhibition and an associated enhancement of N-type Ca2+ current in rat sympathetic neurons. The muscarinic modulation was attenuated when arachidonic acid production by PLA2 was blocked. The authors also showed that the CaV β-subunit is important in determining the channel modulation by GqPCRs (21). In their hypothesis, the palmitoyl chains of the CaV β2a-subunit interact directly with CaV2.2 channels and competitively block receptor-stimulated current suppression by arachidonic acid (30).

In recent studies, we characterized the ability of a voltage-sensing lipid phosphatase from zebrafish (Dr-VSP) (3133) to deplete membrane PIP2 (34). Activation of Dr-VSP using a +120 mV-depolarizing pulse depletes plasma membrane PI(4,5)P2 within a second by removing the 5-phosphate and leaving PI(4)P (10). This tool is useful for experimental protocols that require reversible PIP2 depletion. In cells transfected with various α1-subunits coexpressed with β3- and α2δ1-subunits, we demonstrated that CaV1.2, -1.3, -2.1, and -2.2 channels are partially inhibited when membrane PIP2 is depleted. We report here that (i) the β-subunit affects sensitivity of CaV channels to PIP2 and (ii) it is the palmitoylation of rat β2a that reduces the functional effects of PIP2 in CaV channels. Our data are consistent with previous studies showing that, of several β-subunits tested (β1b, β2a, and β3), β2a is the most effective at suppressing Gq protein-mediated Ca2+ channel inhibition in neurons (35).

Results

PIP2 Regulation of CaV Currents Depends on the CaV β-Subunit.

In our previous study, we found that four CaV α1-subunits coexpressed with β3- and α2δ1-subunits gave currents sensitive to PIP2 depletion (10). In this study we show that the extent of PIP2 modulation depends on which β-subunit is used. Our standardized protocol involved a test pulse (pulse a) to record baseline channel current, then a 1-s depolarization to +120 mV to activate Dr-VSP and deplete PIP2, next a hyperpolarizing pulse for 0.4 s to remove any Ca2+ channel inactivation, followed finally by a second test pulse (pulse b) (Fig. 1A). We compared the a and b currents. Without the large depolarizing pulse to +120 mV, there was no significant difference between currents a and b (10). Similarly in control cells not expressing Dr-VSP, the CaV2.2 current amplitudes were almost the same before (trace a) and after (trace b) the 1-s depolarization in cells cotransfected with either β3- or β2a-subunits (Fig. 1A, Top, and B). In contrast, with expression of Dr-VSP, the 1-s depolarizing pulse significantly attenuated the current in pulse b in cells with β3-subunits but hardly had any effect in cells with β2a-subunits (Fig. 1A, Bottom, and B). The prominent tail currents of CaV2.2 channels were inhibited to the same degree as the peak inward currents during test pulses (Fig. 1A). Dr-VSP activation did not change the activation or deactivation kinetics of expressed currents. Our findings with PIP2 modulation are reminiscent of those of others that coexpression of β2a-subunits greatly attenuates M1 muscarinic inhibition of CaV currents (21).

Fig. 1.

Fig. 1.

CaV β-subunits determine CaV2.2 channel sensitivity to PIP2 depletion. Whole-cell Ba2+ current in tsA-201 cells. (A) Cells transfected with CaV α1B (CaV2.2), α2δ1, and β3 (Left) or β2a (Right) subunits received a test pulse (a), then a depolarization to +120 mV for 1 s, a hyperpolarization to −150 mV for 0.4 s, and a second test pulse (b). The currents before (a) and after (b) the depolarizing pulse are presented in control (Upper) and Dr-VSP–expressing (Lower) cells. Peak tail current is indicated by arrowheads (trace a, open head; trace b, closed head). (B) Summary of CaV2.2 current inhibition (%) by the strong depolarizing pulse in control and Dr-VSP–expressing cells cotransfected with CaV β3- or β2a-subunits. Control, n = 5 for β3 and for β2a; Dr-VSP, n = 11 for b3 and n = 15 for β2a. (C) CaV2.2 current modulation by M2 muscarinic receptor activation with 10 μM Oxo-M in cells expressing β3 (Upper) or β2a (Lower). (Insets) Current traces before (a) and during (b) Oxo-M application. (D) Summary of M2 muscarinic suppression of CaV2.2 currents with β3 (n = 6) or β2a (n = 5).

In addition to slow Gq-coupled modulation by the M1 muscarinic receptor, CaV2.2 channels are subject to a fast Gi/o-coupled modulation by M2 muscarinic receptors (36). The Gβγ-subunits released from Gi/o inhibit CaV2.2 channels by binding directly to the α1-channel subunit (37, 38). We tested the effects of CaV β-subunits on modulation of CaV2.2 channels by M2 muscarinic receptors. Fig. 1C shows that the current modulation by M2 receptor was not significantly different between channels with β3- and β2a-subunits. We also considered whether the N-terminal Gβγ binding site on the CaV2.2 α1-subunit governs PIP2 regulation. For the test we took advantage of the Gβγ-insensitivity of a chimeric channel construct α1C-1B (10, 39). In this chimera, the N terminus of CaV2.2 (N-type, α1B-subunit), which includes one of the Gβγ binding sites, is replaced by the N terminus of CaV1.2 (L-type, α1C-subunit). As shown in Fig. S1, PIP2 regulation of chimeric CaV2.2 channels was still dramatically reduced in cells expressing the CaV β2a-subunit. Thus, the β-subunit–specific differential regulation of CaV channels by PIP2 depletion does not generalize to regulation by Gβγ-subunits and does not depend on the N terminus of CaV2.2 channels where there is a Gβγ binding site.

We next tested whether regulation by PIP2 of two other CaV channels (1.3 and 2.1) depends on the expressed β-subunit. For both channels, activation of Dr-VSP inhibited current much better in the presence of CaV β3-subunits than in the presence of CaV β2a-subunits (Fig. 2), echoing the findings for CaV 2.2 channels in Fig. 1.

Fig. 2.

Fig. 2.

CaV β-subunits set sensitivity of CaV2.1 and CaV1.3 channels to Dr-VSP. (A) Differential regulation of CaV2.1 channels by Dr-VSP. Typical CaV2.1 current with β3 (Left) or β2a (Right) before (a) and after (b) Dr-VSP activation in control (Upper) and Dr-VSP–expressing (Lower) cells. Arrowheads are peak tail currents. (B) Summary of the percent inhibition of CaV2.1 currents by Dr-VSP activation. For control, β3 (n = 7), β2a (n = 6); for Dr-VSP, β3 (n = 6), β2a (n = 6). (C) Inhibition of L–type CaV1.3 currents by PIP2 depletion. (Left) Superimposed currents before (a) and after (b) the depolarizing pulse. (Right) Summary of the current inhibition by the +120-mV depolarizing pulse with β3 (n = 3) or β2a (n = 4).

Palmitoylation Determines PIP2 Modulation of CaV2.2 Channels.

We considered the effect of β-subunits on CaV2.2 channels in more depth. The CaV β-subunits are key determinants of channel inactivation gating kinetics. Fig. 3A shows representative CaV2.2 currents normalized to peak current in cells with β2a, β2b, or β3-subunits. The current inactivation in cells transfected with β2a was slow, whereas for cells transfected with β3- and β2b-subunits it was fast (Fig. 3 A and B). These data are consistent with the previously reported ability of β2a to slow voltage-gated inactivation of CaV2.3 (α1E) (27). We then tested whether the palmitoylation of the β2a-subunit affects modulation by PIP2 and is required for slowing inactivation. We used the palmitoylation-resistant mutant β2a(C3S,C4S), where both palmitoylated cysteine residues are replaced with serine (28). Prevention of lipidation changed the effects of the β2a-subunit so they were much closer to those of β2b- or β3-subunits in three ways. With the β2a(C3S,C4S) subunit: (i) Current inactivation was speeded to resemble β2b- or β3-subunits (Fig. 3B); (ii) the current density fell from the high value seen with β2a to the lower value seen with β2b and β3 (Fig. S2A); and (iii) the inhibition by PIP2 depletion increased (Fig. 3C). Current inhibition with Dr-VSP was 9 ± 2% (n = 6) with β2a, 41 ± 3% (n = 6) with β2b, and 27 ± 4% (n = 8) with β2a(C3S,C4S). We also found that, with the expression of another nonpalmitoylated subunit, β1b, the activation of Dr-VSP significantly attenuated the current (36 ± 3%, n = 4) (Fig. S3).

Fig. 3.

Fig. 3.

Palmitoylation of CaV β-subunit attenuates inactivation gating and inhibition by PIP2 depletion. (A) Differential effects of CaV β-subunits on the inactivation of CaV2.2 currents. Currents with different CaV β-subunits were measured during 500-ms test pulses to +10 mV or +30 mV in control cells. Overlaid current traces with different CaV β-subunits are scaled to the peak amplitude (I0). Dashed line indicates zero current. (B) CaV2.2 current inactivation during the 500-ms depolarizing pulse calculated as final current amplitude (I) divided by initial peak (I0) in cells expressing different β-subunits. Currents measured at +10 mV or +30 mV in control cells with no Dr-VSP. (C) Inhibition of CaV2.2 currents by Dr-VSP with various β-subunits. Currents in test pulses to +10 mV for 10 ms before (a) and after (b) the depolarizing pulse are superimposed. (D) Summary of the CaV2.2 current inhibition (%) by depolarization in control and Dr-VSP-expressing cells transfected with different CaV β-subunits; for control, β2a (n = 4), β2a(C3S,C4S) (n = 4), or β2b (n = 4); for Dr-VSP, β2a (n = 6), β2a(C3S,C4S) (n = 8), or β2b (n = 6). *P < 0.01, compared with β2a.

Targeting of the β3-Subunit to the Membrane.

The β3-subunits are soluble cytosolic proteins that bind to α1-subunits of Ca2+ channels. We examined the effects of anchoring β3-subunits to the membrane by adding an N-terminal 13 residue sequence of Lyn to the N terminus of β3. This chimera starts with GCIKS, where the G and C become myristoylated and palmitoylated, respectively. Confocal imaging shows that wild-type β3-subunits are distributed throughout the cytoplasm in the presence or absence of other subunits of CaV2.2 channels (Fig. 4A, Left). In contrast, with the added N terminus of Lyn, chimeric β3-proteins were mostly associated with the plasma membrane, even without expression of α1-subunits (Fig. 4A, Right, and Fig. S4A). The distribution of Lyn-β3-YFP was comparable that of the PIP2 binding protein CFP-PH domain, which targets the cytoplasmic leaflet of the plasma membrane (Fig. S4B). Addition of lipidation sites changed the effects of the β3-subunit so they were more like those of palmitoylated β2a-subunits in three ways. With the Lyn-β3 subunit: (i) inactivation of CaV2.2 currents was slowed approximately twofold (Fig. 4C) compared with currents with the nonlipidated wild-type β3-subunit (Fig. 4B); (ii) the current density of the CaV2.2 channels was significantly enhanced (Fig. 4D); and (iii) inhibition by PIP2 was blunted compared with cells with β3 (Fig. 4E). With the β3-subunits, currents were inhibited by 52 ± 2% (n = 6), whereas with Lyn-β3, currents were inhibited by 24 ± 3% (n = 6) (Fig. 4F).

Fig. 4.

Fig. 4.

Membrane targeting of CaV β3-subunit attenuates current inactivation and Dr-VSP–induced inhibition. (A) Confocal images of cells expressing cytosolic β3-YFP or membrane-targeted Lyn-β3-YFP without (Upper) or with (Lower) other CaV2.2 channel subunits. (Scale bars, 10 μm.) (B) Effect of membrane-targeted CaV Lyn-β3 on the inactivation of CaV2.2 currents. Currents were measured during 500-ms test pulses to +10 mV or +30 mV in control cells. Blue lines are current traces with Lyn-β3-YFP scaled to the peak amplitude of currents with β3-YFP. (C) Summary of the time constants for current inactivation. Data are mean ± SEM. (D) CaV2.2 current density (pA/pF) measured in cells expressing CaV2.2 channels with β3, β3-YFP, or Lyn-β3-YFP. Cells were transfected with the same amounts of cDNA. Average membrane capacitances for cells are 20 ± 3 pF for β3 (n = 5), 24 ± 3 for β3-YFP (n = 6), and 25 ± 7 for Lyn-β3-YFP (n = 6). (E) Currents in CaV2.2 channels with β3-YFP (Left) or Lyn-β3-YFP (Right) before (a) and after (b) a strong depolarizing pulse in Dr-VSP-expressing cells. The peak tail currents are indicated by arrowheads. (F) Summary of inhibition by PIP2 depletion in cells with β3-YFP or Lyn-β3-YFP. Data are mean ± SEM. *P < 0.01, compared with β3-YFP.

β-Subunits Can Grade the Modulation of CaV Channels.

In physiological conditions, a single excitable cell expresses multiple types of CaV β-subunits and other subunits (20, 21). To mimic this situation, tsA cells transfected with both β2a- plus β3-subunits were compared with cells transfected with only one of them. The CaV2.2 current inactivation was measured at +10 and +30 mV. Fig. 5A shows that current inactivation in cells expressing both β-subunits looked like a mixture of some channels complexed with β3-subunits and a second population complexed with β2a-subunits. On average in cells transfected with equal quantities of β2a- and β3-subunit cDNAs, a little more than half of the current showed β2a inactivation (I/I0) kinetics (Fig. 5A, Lower). This overrepresentation of β2a-like actions might be expected if β2a-subunits are more efficient at bringing functional channels to the surface. Next, the PIP2 sensitivity of the currents was measured. Considering again that cells expressing both the β2a- and β3-subunits have a mixture of two channel complexes, the Dr-VSP–mediated current inhibition suggested that a little more than half the current comes from channels complexed with β2a-subunits that reduce their sensitivity to PIP2 depletion (Fig. 5 B and C).

Fig. 5.

Fig. 5.

CaV β-subunits determine channel modulation by receptors. (A) Coexpression of CaV β2a with β3-subunits slows the inactivation of CaV2.2 currents. Current inactivation was measured during a 500-ms test pulse in cells expressing β3 (0.5 μg), or β2a (0.5 μg), or β3 (0.25 μg) plus β2a (0.25 μg). Current traces with β3 (blue) or β3 plus β2a (red) are scaled to the peak amplitude of current with β2a (black). (Lower) Summary of current inactivation [final current amplitude (I) divided by the initial current (I0)] at +10 mV (n = 7) and +30 mV (n = 6). (B) Current inhibition by PIP2 depletion in cells coexpressing β2a- and β3-subunits. Cells received a test pulse (a), then were depolarized to +120 mV for 1 s and hyperpolarized to −150 mV for 0.4 s, followed by the second test pulse (b). Currents before (a) and after (b) the depolarizing pulse are superimposed. Peak tail currents are indicated by arrowheads. (C) Summary of the CaV2.2 current inhibition (%) by depolarization in Dr-VSP–expressing cells transfected with various CaV β-subunits. (D) Current inhibition by M1 muscarinic receptor activation with Oxo-M (10 μM) in cells expressing β3 or β2a. (Insets) Current traces for before (a) and during (b) Oxo-M application are overlaid. (E) Summary of the M1 muscarinic suppression of the CaV2.2 currents in cells expressing various β-subunits. (n = 5 for control, n = 7 for β2a).

Finally, the effect of β-subunits on slow muscarinic modulation of CaV2.2 channels was tested in cells expressing M1Rs. In cells expressing β3-subunits, stimulation with Oxo-M strongly decreased the CaV2.2 current (Fig. 5 D and E). The effect was somewhat weaker in cells with β2a-subunits and possibly intermediate with β2a(C3S,C4S), β2b, or a mixture of β2a and β3. The muscarinic modulation was stronger than the PIP2 modulation, and the effects of changing subunits were weaker on muscarinic compared with PIP2 modulation.

Discussion

The CaV β2a isoform is a β2 splice variant that differs from β2b only in the N terminus where it contains the determinants of palmitoylation at Cys3 and 4. Among CaV β-subunits, β2a is functionally unique. We have extended early findings on its ability, in comparison with the other β-subunits: (i) to localize to the plasma membrane by itself (23, 24), (ii) to enhance functional CaV channel expression (22, 40), (iii) to slow and minimize inactivation gating during membrane depolarization (27, 28), and (iv) to reduce slow suppression of current by GqPCR signaling (21, 30). Another unique property is that (v) the β2a-subunit prevents inhibition of CaV currents by direct application of arachidonic acid (21). All of the well-documented properties listed above depend on palmitoylation of the β-subunit. When the palmitoylation sites are removed or the palmitoylation reaction is blocked, the β2a-subunit loses these unique properties and behaves more like the others. We have added another unique property: the β2a-subunit (vi) greatly reduces the sensitivity of several CaV channels to PIP2 depletion. This property too is lost when the palmitoylation sites are defective and can be conferred on another β-subunit simply by appending a lipidation motif. In our experiments with the β3-subunit, N-type channels (CaV2.2) are the most sensitive to PIP2 depletion (∼50–60%) and other channels, such as L-type (CaV1.3) and P/Q-type (CaV2.1), are inhibited by 20–30%. However, with β2a-subunits, all of the types of CaV channels are inhibited only <10–15% by PIP2 depletion. Thus, the PIP2 regulation of CaV channels is dependent on both the α1- (10) and β-subunits.

What is the situation in a really excitable cell that expresses several subtypes of CaV β-subunit? The channel properties will represent a mixture of channel complexes. Different cells could tune their CaV functional properties and expression by adjusting their mix of β-subunits and the degree of palmitoylation, which would affect the amplitude, inactivation behavior, and modes of modulation of channel current. Apparently some β-subunits can be exchanged from the channel complex within a few minutes (41). Previous studies reported that superior cervical ganglion neurons express multiple types of β-subunit with β2a and β3 being the major isoforms (21). In the superior cervical ganglion, channel inactivation is very slow compared with that in an expression system with β3 subunits (21, 42). That finding might suggest that most of the endogenous CaV2.2 channels are complexed with β2a-subunits. However, that conclusion would be inconsistent with many findings that the native channels are relatively sensitive to modulation by GqPCRs, PIP2 depletion, and arachidonic acid, as if complexed with β3-subunits. Future work will need to examine the possible involvement of β3-subunits in a more quantitative way. Bovine chromaffin cells express several subtypes of β-subunits including β2a and β3 and their N-type currents are almost noninactivating as in the superior cervical ganglion (43). The currents are also significantly inhibited by GPCRs through voltage-independent pathways (44). In contrast, mouse aorta expresses both β2a- and β3-subunits, and the calcium current is strongly inactivating. In the aorta of β3-null mice; however, the L-type current inactivation became slower by ∼twofold (45). The β2a-subunit is broadly expressed in brain, heart, and aorta, but its expression is lower than other β-subunits (46, 47), with β3 being predominant and the most abundant β-subunit in neuronal N-type channel complexes (47, 48).

Palmitoylation adds a 16-carbon fatty acid chain covalently to cysteine residues (49). The reversibility of palmitoylation introduces the possibility that the constellation of effects of β2a is under dynamic control through physiological signals. Indeed, in the experiments of Hurley et al. (28) it was suggested from observing different current time courses that some individual cells had more palmitoylation on their β2a-subunits than others. In some manner the palmitoylation confers numerous special functional properties on the β-subunit. The addition of hydrophobic palmitates should anchor the N terminus of the β2a-subunit more tightly to the lipid bilayer, increasing the probability that channels would encounter and complex with a β2a-subunit compared with a nonlipidated soluble β3-subunit. Partnering with an anchored subunit may also favor a special stabilizing conformational transition of the channel that affects its probability of being open.

As suggested extensively by the Rittenhouse laboratory (4, 21, 30), the β2a-subunit palmitates may be ligands that interact specifically with the channel as well. In their view, which is plausible, the closely tethered palmitoyl chains interact with a binding site on the channel that can otherwise interact with other fatty acid tails, including the arachidonic acid that is essential in their favored model and those of the PIP2 that is essential in our model. If this competitive concept is correct, then an active form of the channel is stabilized by β-subunits with the palmitate or by PIP2, and an inactive form is stabilized by the arachidonate. The two active forms would have somewhat different properties. The palmitate-occupied form would be noninactivating or poorly inactivating, whereas the PIP2-occupied form would be a channel that can inactivate “normally.” It is tempting to think that modulation by GqPCRs, and by arachidonic acid addition, and by PIP2 depletion show the same sensitivity to the specific β-subunit expressed because they all share this same competitive interaction at a hydrophobic site on the channel.

We had tended to emphasize the PIP2 headgroup and to de-emphasize the fatty-chain hypothesis both because in many channels the function of long-chain native PIP2 can be mimicked by the soluble, short-chain version diC8-PIP2 (suggesting little lipid specificity) and because, as our VSP experiments confirm, PI(4)P cannot substitute for PI(4,5)P2 in maintaining channel function. A recent crystal structure of an inward rectifier Kir2.2 channel with phosphoinositides and our finding that channels with lipidated β2a subunits do not need PIP2, strengthen the fatty chain hypothesis (50). The cytoplasmic domain of Kir2.2 has a stereo-specific binding site for the inositol phosphate ring, and the transmembrane domain has a nonspecific phospholipid binding site that will interact even with the short-chains on diC8-PIP2 and with other phospholipids. Binding of diC8-PIP2 across both domains draws them together, stabilizing an active open state. Thus, by analogy there may be two regions on the channels we have studied that are drawn together by the bidentate PIP2 but not by binding of arachidonic acid, which lacks an interacting headgroup. Nonlipidated β-subunits that act only on cytoplasmic domains of the channel would not interfere with either site, but lipidated ones would be bidentate. These subunits might compete for the phospholipid site by displacing PIP2 or arachidonic acid and thus “cross-link” the transmembrane domain to their normal binding site on the cytoplasmic domain. Virtually the same concept was advanced for CaV channels by Roberts-Crowley et al. (4) who proposed that “the phospholipid acts as Velcro between two regions.”

In short, there seem to be competitive interactions of fatty acid tails on a transmembrane part of the channel, and, for activating ligands, there may be simultaneous binding to a second cytoplasmic domain of the channel complex that physically locks this cytoplasmic domain to the transmembrane component in an activating position. Thus, PIP2 and lipidated β subunits would be adaptor molecules that activate channels by bridging two domains.

Materials and Methods

All methods and materials including the clones are presented in the SI Materials and Methods. In brief, all experiments used cultured HEK tsA-201 cells transiently transfected with various cDNAs, plated onto poly-l-lysine-coated coverslip chips, and studied within 1–2 d. For Ca2+ channel expression, cells were transfected with the CaV α1-subunit, β-subunit, and α2δ1 in a 1:1:1 molar ratio. Whole-cell currents were measured at room temperature (22–25 °C) using a HEKA EPC-9 amplifier (HEKA Elektronik). Quantitative data are expressed as the mean ± SEM, and comparison between two groups used Student t test. Ba2+ currents were recorded during test pulses to –10 mV, 0 mV, or +10 mV to measure CaV1.3, CaV2.1, or CaV2.2 currents, respectively. The external Ringer's solution for electrophysiology contained: 150 mM NaCl, 10 mM BaCl2, 1 mM MgCl2, 10 mM Hepes, and 8 mM glucose, adjusted to pH 7.4 with NaOH. The pipette solution contained: 175 mM CsCl, 5 mM MgCl2, 5 mM Hepes, 0.1 mM 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid (BAPTA), 3 mM Na2ATP, and 0.1 mM Na3GTP, titrated to pH 7.4 with CsOH. For confocal imaging, tsA or HEK293 cells were imaged 24–48 h after transfection on poly-l-lysine coated coverslips. Primers are listed in Table S1.

Supplementary Material

Supporting Information

Acknowledgments

We thank Drs. Duk-Su Koh, Eamonn J. Dickson, Martin Kruse, and Diane Lipscombe for valuable discussions; Mark W. Moody for plasmid amplification; Lea M. Miller for technical assistance; and many laboratories for plasmids (see SI Materials and Methods). This work was supported by National Institutes of Health Grant NS08174 (to B.H.); the Daegu Gyeongbuk Institute of Science and Technology Research and Development Program of the Ministry of Education, Science, and Technology of Korea Grant 12-BD-0403 (to B.-C.S.); and the Human Frontier Science Program (B.H.F.).

Footnotes

The authors declare no conflict of interest.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1121434109/-/DCSupplemental.

References

  • 1.Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev. 2005;57:411–425. doi: 10.1124/pr.57.4.5. [DOI] [PubMed] [Google Scholar]
  • 2.Haley JE, et al. Muscarinic inhibition of calcium current and M current in Gαq-deficient mice. J Neurosci. 2000;20:3973–3979. doi: 10.1523/JNEUROSCI.20-11-03973.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 2000;16:521–555. doi: 10.1146/annurev.cellbio.16.1.521. [DOI] [PubMed] [Google Scholar]
  • 4.Roberts-Crowley ML, Mitra-Ganguli T, Liu L, Rittenhouse AR. Regulation of voltage-gated Ca2+ channels by lipids. Cell Calcium. 2009;45:589–601. doi: 10.1016/j.ceca.2009.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Buraei Z, Yang J. The ß subunit of voltage-gated Ca2+ channels. Physiol Rev. 2010;90:1461–1506. doi: 10.1152/physrev.00057.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Melliti K, Meza U, Adams B. Muscarinic stimulation of α1E Ca channels is selectively blocked by the effector antagonist function of RGS2 and phospholipase C-β1. J Neurosci. 2000;20:7167–7173. doi: 10.1523/JNEUROSCI.20-19-07167.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wu L, Bauer CS, Zhen XG, Xie C, Yang J. Dual regulation of voltage-gated calcium channels by PtdIns(4,5)P2. Nature. 2002;419:947–952. doi: 10.1038/nature01118. [DOI] [PubMed] [Google Scholar]
  • 8.Gamper N, Reznikov V, Yamada Y, Yang J, Shapiro MS. Phosphatidylinositol [correction] 4,5-bisphosphate signals underlie receptor-specific Gq/11-mediated modulation of N-type Ca2+ channels. J Neurosci. 2004;24:10980–10992. doi: 10.1523/JNEUROSCI.3869-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Michailidis IE, Zhang Y, Yang J. The lipid connection-regulation of voltage-gated Ca2+ channels by phosphoinositides. Pflugers Arch. 2007;455:147–155. doi: 10.1007/s00424-007-0272-9. [DOI] [PubMed] [Google Scholar]
  • 10.Suh BC, Leal K, Hille B. Modulation of high-voltage activated Ca2+ channels by membrane phosphatidylinositol 4,5-bisphosphate. Neuron. 2010;67:224–238. doi: 10.1016/j.neuron.2010.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yang J, Tsien RW. Enhancement of N- and L-type calcium channel currents by protein kinase C in frog sympathetic neurons. Neuron. 1993;10:127–136. doi: 10.1016/0896-6273(93)90305-b. [DOI] [PubMed] [Google Scholar]
  • 12.Perez-Burgos A, et al. Muscarinic M1 modulation of N and L types of calcium channels is mediated by protein kinase C in neostriatal neurons. Neuroscience. 2008;155:1079–1097. doi: 10.1016/j.neuroscience.2008.06.047. [DOI] [PubMed] [Google Scholar]
  • 13.Liu L, Rittenhouse AR. Arachidonic acid mediates muscarinic inhibition and enhancement of N-type Ca2+ current in sympathetic neurons. Proc Natl Acad Sci USA. 2003;100:295–300. doi: 10.1073/pnas.0136826100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Liu L, et al. M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades. J Neurosci. 2006;26:11588–11598. doi: 10.1523/JNEUROSCI.2102-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kammermeier PJ, Ruiz-Velasco V, Ikeda SR. A voltage-independent calcium current inhibitory pathway activated by muscarinic agonists in rat sympathetic neurons requires both Gαq/11 and Gβγ. J Neurosci. 2000;20:5623–5629. doi: 10.1523/JNEUROSCI.20-15-05623.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Meza U, Thapliyal A, Bannister RA, Adams BA. Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels. Mol Pharmacol. 2007;71:284–293. doi: 10.1124/mol.106.028530. [DOI] [PubMed] [Google Scholar]
  • 17.Dolphin AC. G protein modulation of voltage-gated calcium channels. Pharmacol Rev. 2003;55:607–627. doi: 10.1124/pr.55.4.3. [DOI] [PubMed] [Google Scholar]
  • 18.Tedford HW, Zamponi GW. Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev. 2006;58:837–862. doi: 10.1124/pr.58.4.11. [DOI] [PubMed] [Google Scholar]
  • 19.Dai S, Hall DD, Hell JW. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev. 2009;89:411–452. doi: 10.1152/physrev.00029.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Scott VE, et al. β subunit heterogeneity in N-type Ca2+ channels. J Biol Chem. 1996;271:3207–3212. doi: 10.1074/jbc.271.6.3207. [DOI] [PubMed] [Google Scholar]
  • 21.Heneghan JF, et al. The Ca2+ channel β subunit determines whether stimulation of Gq-coupled receptors enhances or inhibits N current. J Gen Physiol. 2009;134:369–384. doi: 10.1085/jgp.200910203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chien AJ, et al. Roles of a membrane-localized β subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem. 1995;270:30036–30044. doi: 10.1074/jbc.270.50.30036. [DOI] [PubMed] [Google Scholar]
  • 23.Chien AJ, Carr KM, Shirokov RE, Rios E, Hosey MM. Identification of palmitoylation sites within the L-type calcium channel β2a subunit and effects on channel function. J Biol Chem. 1996;271:26465–26468. doi: 10.1074/jbc.271.43.26465. [DOI] [PubMed] [Google Scholar]
  • 24.Chien AJ, Gao T, Perez-Reyes E, Hosey MM. Membrane targeting of L-type calcium channels. Role of palmitoylation in the subcellular localization of the β2a subunit. J Biol Chem. 1998;273:23590–23597. doi: 10.1074/jbc.273.36.23590. [DOI] [PubMed] [Google Scholar]
  • 25.Shaul PW, et al. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996;271:6518–6522. doi: 10.1074/jbc.271.11.6518. [DOI] [PubMed] [Google Scholar]
  • 26.Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae. J Cell Biol. 1994;126:353–363. doi: 10.1083/jcb.126.2.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Qin N, et al. Unique regulatory properties of the type 2a Ca2+ channel β subunit caused by palmitoylation. Proc Natl Acad Sci USA. 1998;95:4690–4695. doi: 10.1073/pnas.95.8.4690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hurley JH, Cahill AL, Currie KP, Fox AP. The role of dynamic palmitoylation in Ca2+ channel inactivation. Proc Natl Acad Sci USA. 2000;97:9293–9298. doi: 10.1073/pnas.160589697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Delmas P, Coste B, Gamper N, Shapiro MS. Phosphoinositide lipid second messengers: New paradigms for calcium channel modulation. Neuron. 2005;47:179–182. doi: 10.1016/j.neuron.2005.07.001. [DOI] [PubMed] [Google Scholar]
  • 30.Mitra-Ganguli T, Vitko I, Perez-Reyes E, Rittenhouse AR. Orientation of palmitoylated CaVβ2a relative to CaV2.2 is critical for slow pathway modulation of N-type Ca2+ current by tachykinin receptor activation. J Gen Physiol. 2009;134:385–396. doi: 10.1085/jgp.200910204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Murata Y, Iwasaki H, Sasaki M, Inaba K, Okamura Y. Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor. Nature. 2005;435:1239–1243. doi: 10.1038/nature03650. [DOI] [PubMed] [Google Scholar]
  • 32.Halaszovich CR, Schreiber DN, Oliver D. Ci-VSP is a depolarization-activated phosphatidylinositol-4,5-bisphosphate and phosphatidylinositol-3,4,5-trisphosphate 5′-phosphatase. J Biol Chem. 2009;284:2106–2113. doi: 10.1074/jbc.M803543200. [DOI] [PubMed] [Google Scholar]
  • 33.Okamura Y, Dixon JE. Voltage-sensing phosphatase: Its molecular relationship with PTEN. Physiology (Bethesda) 2011;26:6–13. doi: 10.1152/physiol.00035.2010. [DOI] [PubMed] [Google Scholar]
  • 34.Falkenburger BH, Jensen JB, Hille B. Kinetics of PIP2 metabolism and KCNQ2/3 channel regulation studied with a voltage-sensitive phosphatase in living cells. J Gen Physiol. 2010;135:99–114. doi: 10.1085/jgp.200910345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Qin N, Platano D, Olcese R, Stefani E, Birnbaumer L. Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel α1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci USA. 1997;94:8866–8871. doi: 10.1073/pnas.94.16.8866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hille B. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci. 1994;17:531–536. doi: 10.1016/0166-2236(94)90157-0. [DOI] [PubMed] [Google Scholar]
  • 37.Ikeda SR. Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits. Nature. 1996;380:255–258. doi: 10.1038/380255a0. [DOI] [PubMed] [Google Scholar]
  • 38.Herlitze S, et al. Modulation of Ca2+ channels by G-protein β γ subunits. Nature. 1996;380:258–262. doi: 10.1038/380258a0. [DOI] [PubMed] [Google Scholar]
  • 39.Agler HL, et al. G protein-gated inhibitory module of N-type (CaV2.2) Ca2+ channels. Neuron. 2005;46:891–904. doi: 10.1016/j.neuron.2005.05.011. [DOI] [PubMed] [Google Scholar]
  • 40.Berrow NS, Campbell V, Fitzgerald EM, Brickley K, Dolphin AC. Antisense depletion of β-subunits modulates the biophysical and pharmacological properties of neuronal calcium channels. J Physiol. 1995;482:481–491. doi: 10.1113/jphysiol.1995.sp020534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Jangsangthong W, Kuzmenkina E, Böhnke AK, Herzig S. Single-channel monitoring of reversible L-type Ca2+ channel CaVα1-CaVβ subunit interaction. Biophys J. 2011;101:2661–2670. doi: 10.1016/j.bpj.2011.09.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Marchetti C, Carbone E, Lux HD. Effects of dopamine and noradrenaline on Ca channels of cultured sensory and sympathetic neurons of chick. Pflugers Arch. 1986;406:104–111. doi: 10.1007/BF00586670. [DOI] [PubMed] [Google Scholar]
  • 43.Cahill AL, Hurley JH, Fox AP. Coexpression of cloned α1B, β2a, and α2/δ subunits produces non-inactivating calcium currents similar to those found in bovine chromaffin cells. J Neurosci. 2000;20:1685–1693. doi: 10.1523/JNEUROSCI.20-05-01685.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Currie KP, Fox AP. Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition. J Neurosci. 1997;17:4570–4579. doi: 10.1523/JNEUROSCI.17-12-04570.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Murakami M, et al. Modified cardiovascular L-type channels in mice lacking the voltage-dependent Ca2+ channel β3 subunit. J Biol Chem. 2003;278:43261–43267. doi: 10.1074/jbc.M211380200. [DOI] [PubMed] [Google Scholar]
  • 46.Hullin R, et al. Calcium channel β subunit heterogeneity: Functional expression of cloned cDNA from heart, aorta and brain. EMBO J. 1992;11:885–890. doi: 10.1002/j.1460-2075.1992.tb05126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Pichler M, et al. β subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem. 1997;272:13877–13882. doi: 10.1074/jbc.272.21.13877. [DOI] [PubMed] [Google Scholar]
  • 48.Vance CL, et al. Differential expression and association of calcium channel α1B and β subunits during rat brain ontogeny. J Biol Chem. 1998;273:14495–14502. doi: 10.1074/jbc.273.23.14495. [DOI] [PubMed] [Google Scholar]
  • 49.Shipston MJ. Ion channel regulation by protein palmitoylation. J Biol Chem. 2011;286:8709–8716. doi: 10.1074/jbc.R110.210005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hansen SB, Tao X, MacKinnon R. Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature. 2011;477:495–498. doi: 10.1038/nature10370. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES